A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.
Hersh, Evan M
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma. [electronic resource] - Cancer Jan 2010 - 155-63 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0008-543X
10.1002/cncr.24720 doi
Aged
Albumin-Bound Paclitaxel
Albumins--adverse effects
Antineoplastic Agents--adverse effects
Disease-Free Survival
Female
Humans
Male
Melanoma--drug therapy
Neoplasm Metastasis
Paclitaxel--adverse effects
Skin Neoplasms--drug therapy
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma. [electronic resource] - Cancer Jan 2010 - 155-63 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0008-543X
10.1002/cncr.24720 doi
Aged
Albumin-Bound Paclitaxel
Albumins--adverse effects
Antineoplastic Agents--adverse effects
Disease-Free Survival
Female
Humans
Male
Melanoma--drug therapy
Neoplasm Metastasis
Paclitaxel--adverse effects
Skin Neoplasms--drug therapy